跳至主要内容
临床试验/NCT05057364
NCT05057364已完成不适用

Heart Smart: A Virtual Self-Management Program for Homebound People With Heart Failure

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2021年9月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
5
试验地点
1
主要终点
Change in Self-Efficacy Measure for Chronic Disease (SEMCD)

研究概览

简要总结

The purpose of this capstone project is to pilot Heart Smart, a virtual group program to improve self-efficacy for self-management skills for homebound people with heart failure.

详细描述

The purpose of this capstone project is to pilot Heart Smart, a virtual group program to improve self-efficacy for self-management skills for homebound people with heart failure. Heart Smart will provide synchronous virtual group education to homebound people with heart failure receiving services from Penn Medicine at Home. The primary clinical goal is to improve self-efficacy for heart failure self-management and improve their knowledge of heart failure self-management strategies. Secondary outcomes will explore the feasibility of the program by exploring technology, adherence and satisfaction with the program.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of heart failure
  • •Receiving home health care from Penn Medicine at Home at time of screening.
  • •Technology capabilities to participate in the program (laptop or tablet with a camera, internet access).
  • •Able to read and write in English.
  • •Cognitive ability to participate in the program if the participant is able to score12/15 on the Montreal Cognitive Assessment (MoCA) 5 Minute Phone Test.

排除标准

  • •Hearing impairment that impacts communication.
  • •Previous experience receiving occupational therapy services from the principal investigator.

研究组 & 干预措施

Heart Smart Group

Experimental

Receives Heart Smart Intervention

干预措施: Heart Smart Virtual Self-Management Group (Other)

结局指标

主要结局

Change in Self-Efficacy Measure for Chronic Disease (SEMCD)

时间窗: At first and final sessions (weeks 1 and 6)

This self-report scale has 6 items which are each rated on a scale of 1 (not at all confident) to 10 (totally confident). The score for the scale is the mean of the scores for the six items. Possible scores are 1-10 with higher scores indicating higher self-efficacy. This scale is an appropriate outcome measure for a heart failure self-management group because it was designed to measure self-efficacy in people with chronic conditions such as heart failure and has undergone psychometric evaluation. This scale is free to use without permission. Administration takes less than 10 minutes.

次要结局

  • Change in Kansas City Cardiomyopathy Questionnaire (KCCQ)(At first and final sessions (weeks 1 and 6))
  • Change in Atlanta Heart Failure Knowledge Test V3 (AHFKT)(At first and final sessions (weeks 1 and 6))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sara Frye, MS OTR/L ATP

Therapy Professional Development Specialist

University of Pennsylvania

研究点 (1)

Loading locations...

相似试验